The effect of a human interferon preparation on vaccine-induced rubella infection.
D000917:Antibody Formation / Q000187:drug effects; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007273:Injections, Intramuscular; D007279:Injections, Subcutaneous; D007372:Interferons / Q000008:administration & dosage*; D007962:Leukocytes / Q000276:immunology; D008297:Male; D012409:Rubella / Q000209:etiology*; D012411:Rubella Vaccine / Q000008:administration & dosage / Q000009:adverse effects*; D012412:Rubella virus / Q000302:isolation & purification
D000998:Antiviral Agents; D012411:Rubella Vaccine; D007372:Interferons